$669.3 M

PLSE Mkt cap, 05-Mar-2021
Pulse Biosciences Net income (Q2, 2020)-11.3 M
Pulse Biosciences Cash, 30-Jun-202037.8 M
Pulse Biosciences EV642.9 M

Pulse Biosciences Income Statement

Pulse Biosciences Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

2.1m3.4m51.1m6.9m

Prepaid Expenses

412.0k779.0k1.0m

Inventories

268.0k

Current Assets

16.7m38.5m60.4m26.4m

PP&E

2.6m2.2m2.6m

Goodwill

2.8m2.8m2.8m2.8m

Total Assets

26.3m49.8m70.6m41.9m

Accounts Payable

265.0k782.0k1.3m2.0m

Current Liabilities

1.0m2.2m3.1m4.5m

Long-term debt

6.7m

Total Debt

6.7m

Total Liabilities

3.8m4.3m11.2m

Common Stock

17.0k21.0k21.0k

Additional Paid-in Capital

37.9m84.2m142.0m153.4m

Retained Earnings

(12.6m)(38.2m)(75.7m)(122.7m)

Total Equity

25.3m46.0m66.3m30.7m

Financial Leverage

1 x1.1 x1.1 x1.4 x

Pulse Biosciences Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(2.8b)(25.6m)(37.5m)(47.0m)

Depreciation and Amortization

167.0m1.0m1.3m1.2m

Inventories

12.0k

Accounts Payable

29.0k517.0k490.0k646.0k

Cash From Operating Activities

(101.0k)(11.1m)(23.9m)(34.2m)

Purchases of PP&E

(46.0k)(2.6m)(276.0k)(608.0k)

Cash From Investing Activities

(45.0k)(23.0m)26.1m(10.1m)

Cash From Financing Activities

7.2m35.4m45.5m82.0k

Net Change in Cash

1.3m47.7m(44.2m)

Pulse Biosciences Ratios

USDQ1, 2016

Financial Leverage

1.1 x

Pulse Biosciences Operating Metrics

FY, 2016

Patent Applications

61

Patents Issued

49